Skip to content

Menu

About Us
Our Science
Newsroom
- Press Releases
- Events & Presentations
Investor Relations
Contact

Close Menu

Pipeline

Menu

Overview of Assets
Science
– Polyamines
– Polyamine Metabolic Inhibitor Technology
Pipeline
Clinical Trials
– Ivospemin
– Flynpovi
Expanded Access Policy

Panbela Combined Pipeline

Quick Links

Home
About Us
Our Science
Newsroom
Investor Relations
Contact

Contact

ir@panbela.com

Sign up to receive press releases via email:

Leave this field empty if you're human:

News & Events

Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101

Panbela Provides Business Update and Reports Q4 and FY 2022 Financial Results

Panbela to Host Fourth Quarter and Year End 2022 Earnings Conference Call on March 16, 2023

Copyright ©2023 Panbela Therapeutics, Inc. All Rights Reserved.